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ABSTRACT: An irreversible, three-component assembly with 2-formylphenylboronic acid, catechol and N-
hydroxylamines was achieved in aqueous media. The boronate ester product was formed with substituted catechols in-
cluding L-DOPA. Assembly was found to be orthogonal to common biological functional groups and both copper(I)-
catalyzed alkyne-azide cycloaddition (CuAAC) and aminoether/carbonyl condensations. Boronate ester formation and 
aminoether condensation were achieved in one-pot with a hexameric peptide.  
There are currently a wide variety of coupling reactions 
being explored for applications in materials chemistry,1–5 
organometallic catalysis,6–10 and chemical biology.11,12 
When these methods proceed under mild conditions, are 
high yielding, and do not generate noxious byproducts, 
they have been termed “click” reactions.13 Those that do 
not involve or react with common biological functional 
groups act in a bioorthogonal fashion.14,15 Developing 
bioorthogonal reactions that label peptides necessarily 
entails the incorporation of an unnatural amino acid or 
chemical modification of one of the common 20 amino 
acids.16–18 Further, the popular coupling methods, except 
for those that are metal-catalyzed, such as the Cu(I)-
catalyzed Sharpless-Huisgen cycloaddition,19 involve reac-
tions that commence immediately upon mixing of the 
components. Thus, overall common bioorthogonal reac-
tions cannot be easily controlled in a spatial or temporal 
manner, and chemical synthesis is required prior to their 
utilization in vitro or in vivo. 
While not bioorthogonal, we have recently described a 
method for a chemically-triggered reversible click reac-
tion that yields the original coupling partners without 
modification.20 In our continued pursuit of methods to 
trigger chemical coupling and decoupling upon demand, 
we explored the use of 2-formylphenylboronic acid (1) as a 
reagent to combine two otherwise unreactive compo-
nents. This work was inspired by the recent Bull and 
James report that 1 can be used to form an assembly that 
acts as a 1H-NMR chiral shift reagent to measure the en-
antiomeric excess values of chiral hydroxylamines when 
in the presence of BINOL in aprotic, organic media 
(Scheme 1).21  
Scheme 1. Boronate ester assembly as published by 
James et al.21 
 
Phenyl boronic acids have been briefly studied in 
bioorthogonal labeling via boronate ester formation with 
dopamine22 and Pd-catalyzed Suzuki couplings.15,23 Be-
cause boronic acids generally have even greater affinities 
to catechols than alkyl diols, and because they bind cate-
chols relatively well in water, we realized that the method 
had the potential to “click” together catechol-
functionalized biological compounds, such as the amino 
acid L-DOPA, with virtually any moiety that carried a 
hydroxylamine. Although L-DOPA is not one of the 
common 20 amino acids, it has been incorporated into 
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both peptides and proteins,24 and therefore provides a 
readily available coupling partner in a semi-bioorthogonal 
fashion.  
Another avenue we were interested in exploring was 
the difference in reactivity between N-functionalized hy-
droxylamines (RNHOH) and O-functionalized hydroxyl-
amines, hereafter referred to as aminoethers (RONH2). 
Aminoethers have been previously reported in bioorthog-
onal couplings,25 but have different reactivity than hy-
droxylamines; we hypothesized that these two isomeric 
functional groups could potentially be paired together 
while retaining their orthogonal reactivity. We demon-
strate herein that the boronic acid-triggered coupling of 
catechols and hydroxylamines indeed works well in water, 
has broad catechol substrate scope, can be used to fluo-
rescently label L-DOPA-containing peptides in vitro, and 
is compatible with couplings involving aminoethers.   
Previous assemblies with 1 and standard amines have 
been shown to form reversibly and are capable of ex-
changing both diol and amine under equilibrium condi-
tions.26,27 These assemblies were also shown to be stabi-
lized by solvent insertion in protic media (2).28 We hy-
pothesized that the hydroxyl group of the hydroxylamine 
would occupy the same geometric position as the oxygen 
of an inserted solvent, and increase the stability of these 
complexes in water (Scheme 2). Since we began work on 
this system, other groups have similarly found that these 
complexes are water stable.29,30 We found that the assem-
bly with catechol (3) formed in water under a variety of 
conditions: neutral water, pH 7 phosphate buffer, pH 5.5 
acetate buffer, and pH 9 bicarbonate buffer. Although the 
addition of Na2CO3 or a similar base is not necessary, it 
does speed assembly formation considerably. A crystal of 
3 grown from slow evaporation of CH2Cl2 shows the coor-
dination of the oxygen from the hydroxylamine to the 
boron, as predicted (Figure 1).  
Scheme 2. a) Formation of a three-component as-
sembly with amine and solvent insertion (2) and b) 
N-hydroxylamine (3) in water with the stabilizing 
oxygen atoms highlighted in red. 
 
  Additionally, we found that assembly 3 is not nearly as 
reversible as the previously reported amine assembly (2). 
Once formed and isolated, 3 is stable to neutral metha-
nol/water mixtures for more than 72 hours with no 
change by 1H-NMR spectroscopy. Although the catechol is 
slowly replaced with hydroxyl groups under strongly basic 
conditions (pH 13), the hydroxylamine addition is irre-
versible and stable to acid (pH 1), base (pH 13), and heat 
(50 °C) over 24 hrs. 
 
Figure 1. Crystal structure showing of 3, grown from CH2Cl2. 
Varying the substitution on the catechol provided a 
range of assemblies; we were also able to complex α-
hydroxy acids and cis-1,2-cyclopentanediol (Scheme 3). 
The determining factors in assembly appear to be solubili-
ty of the diol and strength of its binding to 1. Those that 
were less soluble or bound poorly were unable to out-
compete assembly formation with water, yielding 4.  
Scheme 3. Substrate scope of the three-component 
assembly with N-hydroxylamine in water. 
 
Once compound 4 forms, it does not equilibrate with 
any added catechols to give a different assembly. This 
gives insight into the sequence of steps. To achieve the 
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desired product, the catechol must condense with the 
boronic acid prior to the addition of the hydroxylamine 
into the aldehyde. To support this hypothesis, we exam-
ined the order of addition of the three components to this 
assembly. When 1 and catechol or t-BuNHOH and cate-
chol are combined prior to the addition of the third com-
ponent, the assembly with catechol is formed (Schemes 
4a and 4b). When 1 and t-BuNHOH are combined, the 
condensation occurs prior to catechol addition and is un-
reactive to the catechol (Scheme 4c).  
Scheme 4. Order of addition studies showing a) com-
bination of t-BuNHOH and catechol prior to addi-
tion of 1, b) combination of 1 and catechol prior to 
addition of t-BuNHOH, and c) combination of 1 and 
t-BuNHOH prior to addition of catechol.  
 
Boronic acid complexes are well known for their ability 
to reversibly bind sugars;31 however, the hydroxylamine 
assembly using 1 did not show the same affinity. If fruc-
tose or glucose was combined with 1 and t-BuNHOH, the 
only product was 4. We hypothesize that this is due to the 
low binding constants of boronic acids with sugars with-
out the assistance of an o-aminomethyl group to increase 
binding,32 and once 4 is formed, it will not then exchange 
with an added diol. 
With our desire to transition this assembly to a bio-
compatible platform, we tested the robustness of our 
complex to the presence of common biological functional 
groups with no interferences found (Scheme 5). Addition-
ally, the assembly can be run in parallel with other com-
mon bioorthogonal coupling reactions (Scheme 6); Cu-
AAC chemistry can be used to label azidolysine residues, 
and aldehyde and ketone residues can be labeled using 
aminoethers. The latter is of particular interest due to the 
similarity between hydroxylamine and aminoether struc-
tures, as discussed above. In order to further explore this 
opportunity for orthogonal reactivity, we moved to a pep-
tide scaffold. 
 
 
 
 
Scheme 5. Assembly formation in the presence of 
various functional groups. 
 
Scheme 6. Assembly formation alongside a) CuAAC 
and b) aminoether condensation.  
 
Peptide 14 was synthesized using automated solid-
phase synthesis. The benzaldehyde moiety was incorpo-
rated to allow for conjugation of a commercially available 
aminoether fluorescent dye, CF488A. PEG ethers have 
been used in pharmaceuticals to increase hydrophilicity 
and label proteins to increase water solubility and stabil-
ity.33–36 The dual-labeling of 14 was accomplished in a one-
pot fashion (Scheme 7); 14, CF488A, catalytic aniline, and 
the PEGylated hydroxylamine were dissolved in water at 
room temperature. After 1 hour, 1 was added. The dual-
labeled peptide 15 was isolated after 4 hours, and charac-
terized by fluorescence and 11B-NMR spectroscopies, and 
by MS.  
Scheme 7. Dual, one-pot labeling of peptide 14. 
 
In summary, we extended the utility of a three-
component assembly to the purpose of labeling peptides 
containing L-DOPA. We further expanded the substrate 
scope, as well as uncovering the sequence of formation in 
aqueous conditions, and irreversibility of the coupling.  
The three-component assembly discussed herein is thus a 
semi-bioorthogonal coupling reaction, showing no cross-
reactivity with other common “click” reactions when sim-
ultaneously performed in the same pot. 
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